Functional and molecular changes of MSCs in aging

Current Stem Cell Research and Therapy

Volumn 10, Issue 5, 2015, Pages 384-391

  Kuang, Wei ^a   Xu, Xin ^b   Lin, Jiong ^c   Cao, Yang ^c   Xu, Yue ^c   Chen, Lin ^c   Jin, Liang ^d   Tan, Jiali ^c  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SICHUAN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d NONE   (China)

Author keywords

Cell aging; Cell differentiation; Epigenetic regulation; MiRNA; MSC; Oxidative stress; Signaling pathways; Transcription factor

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE REGENERATION; CARTILAGE CELL; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; DNA METHYLATION; DOWN REGULATION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OXIDATIVE STRESS; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; ANIMAL; GENETIC EPIGENESIS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

TRANSCRIPTION FACTOR;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; HUMANS; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84933559180     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X10666150211162933     Document Type: Article

References (115)

1. Tomlinson RE, Silva MJ. Skeletal blood flow in bone repair and maintenance. Bone Res 2013; 1: 311.
2. TheinHan W, Liu J, Tang M, Chen W, Cheng L, Xu HH. Induced pluripotent stem cell-derived mesenchymal stem cell seeding on biofunctionalized calcium phosphate cements. Bone Res 2013; 4: 371-384.
3. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974; 2(2): 83-92.
4. Gerson SL. Mesenchymal stem cells: no longer second class marrow citizens. Nat Med 1999; 5(3): 262-4.
5. Kumar S, Chanda D, Ponnazhagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 2008; 15(10): 711-5.
6. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human. Exp Hematol 2000; 28(6): 707-15.
7. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple. Br J Haematol 1999; 107(2): 275-81.
8. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence. Bone 2003; 33(6): 919-26.
9. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-7.
10. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13(1): 69-80.
11. Galmiche MC, Koteliansky VE, Brière J, Hervé P, Charbord P. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 1993; 82(1): 66-76.
12. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7.
13. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999; 181(1): 67-73.
14. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106(2): 419-27.
15. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31(10): 890-6.
16. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103(5): 1662-8.
17. Gronthos S, Simmons PJ, Graves SE, Robey PG. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001; 28(2): 174-81.
18. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004; 32(5): 414-25.
19. Hwang S, Park SK, Lee HY, et al. miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 2014; 10(14): 00438-4.
20. Cai P, Xue Z, Qi W, Wang H. Adsorbed BMP-2 in polyelectrolyte multilayer films for enhanced early osteogenic differentiation of mesenchymal stem cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2013; 434: 110-7.
21. Neumann K, Endres M, Ringe J, et al. BMP7 promotes adipogenic but not osteo-/chondrogenic differentiation of adult human bone marrow-derived stem cells in high-density micro-mass culture. J Cell Biochem 2007; 102(3): 626-37.
22. Shen B, Bhargav D, Wei A, et al. BMP-13 Emerges as a Potential Inhibitor of Bone Formation. Int J Biol Sci 2009; 5(2): 192-200.
23. Liu C, Weng Y, Yuan T, et al. CXCL12/CXCR4 signal axis plays an important role in mediating bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells. Int J Med Sci 2013; 10(9): 1181-92.
24. Oh SA, Lee HY, Lee JH, et al. Collagen three-dimensional hydrogel matrix carrying basic fibroblast growth factor for the cultivation of mesenchymal stem cells and osteogenic differentiation. Tissue Eng Part A 2012; 18(9-10): 1087-100.
25. Phipps MC, Xu Y, Bellis SL. Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for Mesenchymal Stem Cells by Bone-Mimetic Electrospun Scaffolds. Plos One 2012; 7(7).
26. Qu B, Xia X, Wu HH, Tu CQ, Pan XM. PDGF-regulated miRNA-138 inhibits the osteogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2014; 448(3): 241-7.
27. AM M, SC B, JM M, FP B, CO C, MF P. Chondrogenic differentiation of cultured human mesenchymal stem cells from. Tissue Eng 1998; 4(4): 415-28.
28. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96(19): 10711-6.
29. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to. Muscle Nerve 1995; 18(12): 1417-26.
30. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61(4): 364-70.
31. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal. Blood 2001; 98(9): 2615-25.
32. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in. Proc Natl Acad Sci USA 1995; 92(20): 9363-7.
33. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008; 129(3): 163-73.
34. Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 2006; 5(1): 91-116.
35. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem cells 2004; 22(5): 675-82.
36. Awad HA, Butler DL, Boivin GP, et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 1999; 5(3): 267-77.
37. Bellantuono I, Aldahmash A, Kassem M. Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta 2009; 1792(4): 364-70.
38. Rosenberger RF. The initiation of senescence and its relationship to embryonic cell. Bioessays 1995; 17(3): 257-60.
39. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk N. Human firsttrimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem cells 2007; 25(3): 646-54.
40. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006; 7: 14.
41. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004; 113(2): 160-8.
42. Inoue K, Ohgushi H, Yoshikawa T, et al. The effect of aging on bone formation in porous hydroxyapatite: biochemical and histological analysis. J Bone Miner Res 1997; 12(6): 989-94.
43. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 2002; 71(1): 36-44.
44. Sun Y, Li W, Lu Z, et al. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J 2011; 25(5): 1474-85.
45. Takada I, Kouzmenko AP, Kato S. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 2009; 5(8): 442-7.
46. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in. J Cell Physiol 2009; 218(2): 237-45.
47. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 2008. p. 183-96.
48. Liu TM, Lee EH. Transcriptional Regulatory Cascades in Runx2-Dependent Bone Development. Tissue Eng Part B Rev 2013; 19(3): 254-63.
49. D’Alimonte I, Lannutti A, Pipino C, et al. Wnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells. Stem Cell Rev 2013; 9(5): 642-54.
50. Taipaleenmäki H, Abdallah BM, AlDahmash A, Säämänen AM, Kassem M. Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. Exp Cell Res 2011; 317(6): 745-56.
51. Guerrero F, Herencia C, Almaden Y, et al. TGF-beta Prevents Phosphate-Induced Osteogenesis through Inhibition of BMP and Wnt/beta-Catenin Pathways. Plos One 2014; 9(2).
52. James AW, Leucht P, Levi B, et al. Sonic Hedgehog influences the balance of osteogenesis and adipogenesis in mouse adipose-derived stromal cells. Tissue Eng Part A 2010; 16(8): 2605-16.
53. Fontaine C, Cousin W, Plaisant M, Dani C, Peraldi P. Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem cells 2008; 26(4): 1037-46.
54. James AW, Pan A, Chiang M, et al. A new function of Nell-1 protein in repressing adipogenic differentiation. Biochem Biophys Res Commun 2011; 411(1): 126-31.
55. James AW, Pang S, Askarinam A, et al. Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev 2012; 21(12): 2170-8.
56. Li HX, Luo X, Liu RX, Yang YJ, Yang GS. Roles of Wnt/betacatenin signaling in adipogenic differentiation potential of adiposederived mesenchymal stem cells. Mol Cell Endocrinol 2008; 291(1-2): 116-24.
57. Galli C, Piemontese M, Lumetti S, Manfredi E, Macaluso GM, Passeri G. GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilictitanium surfaces. Clin Oral Implants Res 2013; 24(8): 921-7.
58. James AW, Pang S, Askarinam A, et al. Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev 2012; 21(12): 2170-8.
59. Oliveira FS, Bellesini LS, Defino HL, da Silva Herrero CF, Beloti MM, Rosa AL. Hedgehog signaling and osteoblast gene expression are regulated by purmorphamine in human mesenchymal stem cells. J Cell Biochem 2012; 113(1): 204-8.
60. Plaisant M, Fontaine C, Cousin W, Rochet N, Dani C, Peraldi P. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Stem cells 2009; 27(3): 703-13.
61. Mak KK, Bi Y, Wan C, et al. Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev Cell 2008; 14(5): 674-88.
62. Hong IS, Lee HY, Choi SW, et al. The effects of hedgehog on RNA binding protein Msi1 during the osteogenic differentiation of human cord blood-derived mesenchymal stem cells. Bone 2013; 56(2): 416-25.
63. Yilgor P, Sousa RA, Reis RL, Hasirci N, Hasirci V. Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration. J Mater Sci Mater Med 2010; 21(11): 2999-3008.
64. Jung RE, Windisch SI, Eggenschwiler AM, Thoma DS, Weber FE, Hämmerle CH. A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2. Clin Oral Implants Res 2009; 20(7): 660-6.
65. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to. J Tissue Eng Regen Med 2008; 2(2-3): 81-96.
66. Wang J, Wang X, Sun Z, et al. Stem cells from human-exfoliated deciduous teeth can differentiate into dopaminergic neuron-like cells. Stem Cells Dev 2010; 19(9): 1375-83.
67. Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18(4): 545-59.
68. Chen D, Ji X, Harris MA, et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 1998; 142(1): 295-305.
69. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 1993; 9(1): 57-71.
70. Granero-Moltó F, Myers TJ, Weis JA, et al. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects. Stem cells 2011; 29(10): 1537-48.
71. Crane JL, Zhao L, Frye JS, Xian L, Qiu T, Cao X. IGF-1 Signaling is essential for differentiation of mesenchymal stem cells for peak bone mass. Bone Res 2013; 1: 186.
72. Mutyaba PL, Belkin NS, Lopas L, et al. Notch signaling in mesenchymal stem cells harvested from geriatric mice. J Orthop Trauma 2014; 28(1): 0000000000000064.
73. Mei Y, Bian C, Li J, et al. miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem 2013; 114(6): 1374-84.
74. Deng ZL, Sharff KA, Tang N, et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008; 13: 2001-21.
75. Jensen ED, Gopalakrishnan R, Westendorf JJ. Regulation of gene expression in osteoblasts. Biofactors 2010; 36(1): 25-32.
76. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006; 99(5): 1233-9.
77. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc fingercontaining transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108(1): 17-29.
78. Zheng F, Zhang S, Lu W, et al. Regulation of insulin resistance and adiponectin signaling in adipose tissue by. PLoS One 2014; 9(6): 0101269.
79. Bochkis IM, Shin S, Kaestner KH. Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity. Mol Metab 2013; 2(4): 447-56.
80. Lacasa D, Dos Santos EG, Dieudonne MN, Giudicelli Y. Rapid estradiol activation of AP-1 and CREB in rat white adipocytes. Ann N Y Acad Sci 2002; 973: 423-5.
81. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I. Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol 2002; 37(6): 757-67.
82. Kim J, Ko J. A novel PPAR_2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation. Cell Death Differ 2014; 20(10): 80.
83. Auwerx J, Martin G, Guerre-Millo M, Staels B. Transcription, adipocyte differentiation, and obesity. J Mol Med 1996; 74(7): 347-52.
84. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3(9): 662-73.
85. Villagra A, Gutiérrez J, Paredes R, et al. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J Cell Biochem 2002; 85(1): 112-22.
86. Arnsdorf EJ, Tummala P, Castillo AB, Zhang F, Jacobs CR. The epigenetic mechanism of mechanically induced osteogenic differentiation. J Biomech 2010; 43(15): 2881-6.
87. Hsiao SH, Lee KD, Hsu CC, et al. DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 2010; 400(3): 305-12.
88. Zheng C, Hayes JJ. Structures and interactions of the core histone tail domains. Biopolymers 2003; 68(4): 539-46.
89. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128(4): 693-705.
90. Shen J, Hovhannisyan H, Lian JB, et al. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol 2003; 17(4): 743-56.
91. Tan J, Lu J, Huang W, et al. Genome-wide analysis of histone H3 lysine9 modifications in human mesenchymal stem cell osteogenic differentiation. PLoS One 2009; 4(8): 0006792.
92. Lee HW, Suh JH, Kim AY, Lee YS, Park SY, Kim JB. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol Endocrinol 2006; 20(10): 2432-43.
93. Hassan MQ, Tare R, Lee SH, et al. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol 2007; 27(9): 3337-52.
94. Wei Y, Chen YH, Li LY, et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011; 13(1): 87-94.
95. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
96. Gao B, Zheng L. microRNA expression in rat apical periodontitis bone lesion. Bone Res 2013; 1: 170.
97. Yu KR, Lee S, Jung JW, et al. MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by directly targeting ZMPSTE24. J Cell Sci 2013; 126(Pt 23): 5422-31.
98. Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. elegans. Science 2005; 310(5756): 1954-7.
99. de Lencastre A, Pincus Z, Zhou K, Kato M, Lee SS, Slack FJ. MicroRNAs both promote and antagonize longevity in C. elegans. Curr Biol 2010; 20(24): 2159-68.
100. Grillari J, Hackl M, Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 2010; 11(4): 501-6.
101. Smith-Vikos T, Slack FJ. MicroRNAs and their roles in aging. J Cell Sci 2012; 125(Pt 1): 7-17.
102. Liu T, Fu NN, Song HL, Wang YL, Wu BJ, Shen ZY. Suppression of MicroRNA-203 improves survival of rat bone marrow mesenchymal stem cells through enhancing PI3K-induced cellular activation. IUBMB Life 2014; 23(10).
103. Qu B, Xia X, Wu H-h, Tu C-Q, Pan X-M. PDGF-regulated miRNA-138 inhibits the osteogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2014; 448(3): 241-7.
104. Wu K, Song W, Zhao L, et al. MicroRNA functionalized microporous titanium oxide surface by lyophilization with enhanced osteogenic activity. ACS Appl Mater Interfaces 2013; 5(7): 2733-44.
105. Li H, Xie H, Liu W, et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009; 119(12): 3666-77.
106. Hu R, Liu W, Li H, et al. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 2011; 286(14): 12328-39.
107. Hupkes M, Sotoca AM, Hendriks JM, van Zoelen EJ, Dechering KJ. MicroRNA miR-378 promotes BMP2-induced osteogenic differentiation of mesenchymal. BMC Mol Biol 2014; 15(1): 1471-2199.
108. Trohatou O, Zagoura D, Bitsika V, et al. Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med 2014; 3(1): 54-68.
109. Liu Y, Liu W, Hu C, et al. MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem cells 2011; 29(11): 1804-16.
110. Li M, Fukagawa NK. Age-related changes in redox signaling and VSMC function. Antioxid Redox Signal 2010; 12(5): 641-55.
111. Vigneron A, Vousden KH. p53, ROS and senescence in the control of aging. Aging 2010; 2(8): 471-4.
112. Kume S, Kato S, Yamagishi S, et al. Advanced glycation endproducts attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 2005; 20(9): 1647-58.
113. Sun N, Yang L, Li Y, et al. Effect of advanced oxidation protein products on the proliferation and osteogenic differentiation of rat mesenchymal stem cells. Int J Mol Med 2013; 32(2): 485-91.
114. Zhong ZM, Bai L, Chen JT. Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblast-like cells via NF-kappaB pathway. Cell Physiol Biochem 2009; 24(1-2): 105-14.
115. Liu X, Gong Y, Xiong K, et al. Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells. J Pineal Res 2013; 55(1): 14-25.